UCL Discovery
UCL home » Library Services » Electronic resources » UCL Discovery

Refractory juvenile myoclonic epilepsy: A meta-analysis of prevalence and risk factors

Stevelink, R; Koeleman, BPC; Sander, JW; Jansen, FE; Braun, KPJ; (2018) Refractory juvenile myoclonic epilepsy: A meta-analysis of prevalence and risk factors. European Journal of Neurology 10.1111/ene.13811. (In press). Green open access

[thumbnail of Eur J Neurol - Revision 3 JME manuscript file - Clean document final 120918.pdf]
Preview
Text
Eur J Neurol - Revision 3 JME manuscript file - Clean document final 120918.pdf - Accepted Version

Download (571kB) | Preview

Abstract

BACKGROUND: Juvenile myoclonic epilepsy (JME) is a common epilepsy syndrome for which treatment response is generally assumed to be good. We aimed to determine the prevalence and prognostic risk factors for refractoriness of JME. METHODS: We systematically searched PubMed and Embase and included 43 eligible studies, reporting seizure outcome after anti-epileptic drug treatment JME cohorts. We defined refractory JME as persistence of any seizure despite AED treatment and performed a random-effects meta-analysis to assess the prevalence of refractory JME and of seizure-recurrence after AED withdrawal in individuals with well-controlled seizures. Studies reporting potential prognostic risk factors in relation to seizure outcome were included for subsequent meta-analysis of risk factors for refractoriness. RESULTS: Overall 35% (95%CI: 29 - 41%) of individuals (n=3311) were refractory. There was marked heterogeneity between studies. Seizures recurred in 78% (95%-CI: 52-94%) of individuals who attempted to withdraw treatment after a period of seizure-freedom (n=246). Seizure outcome by publication year suggests that prognosis has not improved over time. Meta-analysis suggested six variables as prognostic factors for refractoriness: having three seizure types, absence seizures, psychiatric comorbidities, earlier age at seizure onset, history of childhood absence epilepsy, and having praxis-induced seizures. CONCLUSION: A third of people with JME were refractory, which is more prevalent than expected. Risk factors were identified and can be used to guide treatment and counselling of people with JME. This article is protected by copyright. All rights reserved.

Type: Article
Title: Refractory juvenile myoclonic epilepsy: A meta-analysis of prevalence and risk factors
Location: England
Open access status: An open access version is available from UCL Discovery
DOI: 10.1111/ene.13811
Publisher version: https://doi.org/10.1111/ene.13811
Language: English
Additional information: This version is the author accepted manuscript. For information on re-use, please refer to the publisher’s terms and conditions.
Keywords: Janz syndrome, epilepsy, meta-analysis, pharmacoresistance, systematic review
UCL classification: UCL
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Brain Sciences
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Brain Sciences > UCL Queen Square Institute of Neurology
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Brain Sciences > UCL Queen Square Institute of Neurology > Clinical and Experimental Epilepsy
URI: https://discovery.ucl.ac.uk/id/eprint/10057216
Downloads since deposit
270Downloads
Download activity - last month
Download activity - last 12 months
Downloads by country - last 12 months

Archive Staff Only

View Item View Item